CONTACT: TOM MOORE
Joint Office for Planning, Marketing and Communications
8788 John Pappajohn Pavilion
Iowa City IA 52242
Release: April 24, 2002
IMPORTANT UPDATE [Posted Oct. 29, 2008] The SELECT study is no longer enrolling participants, and current study
participants will no longer take study medication as of Oct. 27, 2008. Current study participants who would like more information may contact either Diane Meyerholz at email@example.com or 319-356-1111 or Dr. Richard Williams at 319-356-0760.
UI Health Care cancer prevention seminar for men and women set for May
of Iowa Health Care researchers will hold a free educational seminar about
breast and prostate cancer prevention from 6:30 to 8 p.m. Wednesday, May 8
at the Clarion Conference Center, 1220 First Ave., in Coralville.
Adel Al-Jurf, M.D., professor in the UI department of surgery, and Richard
Williams, M.D., professor and head of the UI department of urology, will discuss
risk factors and prevention strategies for both cancers. Their presentations
will be followed by separate overviews of the Study of Tamoxifen and Raloxifene
(STAR) Breast Cancer Prevention Study and the SELECT (focusing on the role
of selenium and Vitamin E) Prostate Cancer Prevention Study. Both research
trials are enrolling participants.
The STAR trial is comparing two medications, tamoxifen and raloxifene, to
determine their effectiveness in preventing breast cancer among postmenopausal
women age 35 or older who are at risk for the disease. The Food and Drug Administration
(FDA) has approved tamoxifen for reducing the rate of invasive breast cancer
among women who are at high risk for the disease. Raloxifene is FDA-approved
for the prevention of osteoporosis among postmenopausal women. Specialists
suggest that raloxifene may have the same ability to prevent breast cancer
as tamoxifen, but that premise needs more study. More than 22,000 women are
expected to enroll in the STAR research trial.
The SELECT study is a research campaign supported by the National Cancer
Institute. Researchers are studying the potential of selenium and vitamin
E supplements in preventing prostate cancer. Research centers for SELECT are
enrolling men who are more than 55 years old.
To register or for more information, call UI Health Access at (319) 384-8442
or toll-free at (800) 777-8442.
University of Iowa Health Care describes the partnership between
the UI Roy J. and Lucille A. Carver College of Medicine and UI Hospitals and
Clinics and the patient care, medical education and research programs and
services they provide. Visit UI Health Care online at www.uihealthcare.com.